Product image of Nodasic (Amisulpride) supplied by GNH India

Nodasic

Active Ingredient:
Amisulpride
Origin:
EU

Nodasic (Amisulpride)

Amisulpride, the active ingredient in Nodasic, is an atypical antipsychotic presented as an oral tablet for oral use. It is prescribed for the treatment of schizophrenia and related psychotic disorders in adults, and it also helps manage depressive symptoms associated with schizophrenia.

GNH India supplies Nodasic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Rafarm Sa.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Amisulpride is used in the management of psychotic disorders by targeting dopaminergic pathways.

  • Schizophrenia: reduces positive and negative symptoms and improves overall functioning.
  • Psychotic disorders: controls acute psychotic episodes and stabilises chronic conditions.
  • Depressive symptoms associated with schizophrenia: alleviates mood disturbances linked to the primary illness.

How It Works

  • Amisulpride acts as a selective dopamine D2/D3 receptor antagonist. At low doses it preferentially blocks presynaptic autoreceptors, enhancing dopaminergic transmission, while at higher doses it blocks postsynaptic receptors, reducing excessive dopamine activity that underlies psychotic symptoms.

Side Effects

Adverse reactions may occur with any antipsychotic therapy.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Headache: transient cranial discomfort.
  • Insomnia: difficulty initiating or maintaining sleep.
  • Anxiety: heightened nervousness or tension.
  • Weight gain: modest increase in body weight.
  • Extrapyramidal symptoms (e.g., akathisia): mild motor restlessness.

Serious or Rare Side Effects

  • Neuroleptic malignant syndrome: life‑threatening reaction with fever and rigidity.
  • Severe hypotension: marked drop in blood pressure.
  • QT‑prolongation: potential cardiac arrhythmia.
  • Agranulocytosis: dangerous reduction in white blood cells.
  • Severe extrapyramidal syndrome: persistent dystonia or parkinsonism.
  • Suicidal ideation: emergence of self‑harm thoughts.

Precautions & Warnings

Careful monitoring is required to minimise risks.

  • Monitor extrapyramidal symptoms: assess for movement disorders regularly.
  • Assess cardiac function: obtain baseline ECG and monitor QT interval.
  • Evaluate metabolic parameters: check weight, glucose, and lipid levels periodically.
  • Use caution in renal impairment: adjust dose if necessary.
  • Avoid abrupt discontinuation: taper under medical supervision.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Amisulpride may interact with several drug classes.

Major Interactions (Avoid)

  • Other dopamine antagonists: increased risk of severe extrapyramidal effects.
  • QT‑prolonging agents (e.g., certain antiarrhythmics): heightened arrhythmia risk.
  • Strong CYP2D6 inhibitors (e.g., fluoxetine): elevated plasma concentrations of amisulpride.

Moderate Interactions (Monitor Closely)

  • Alcohol: may enhance central nervous system depression.
  • Anticholinergic drugs: can mask early signs of movement disorders.
  • Lithium: potential for increased neurotoxicity when combined.

Frequently Asked Questions

Nodasic contains the active ingredient amisulpride and is used to treat schizophrenia, other psychotic disorders, and depressive symptoms that occur in the context of schizophrenia. It helps control hallucinations, delusions, and mood disturbances associated with these conditions.

Amisulpride works by selectively blocking dopamine D2 and D3 receptors. At low doses it blocks presynaptic receptors, enhancing dopamine release, while at higher doses it blocks postsynaptic receptors, reducing excessive dopamine activity that contributes to psychotic symptoms.

The appropriate dose of Nodasic is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Dosage adjustments are made according to therapeutic goals and any observed side effects.

Safety of amisulpride in pregnancy or while breastfeeding has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Nodasic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nodasic (amisulpride) is an atypical antipsychotic that primarily targets dopamine D2/D3 receptors, offering a distinct side‑effect profile compared with agents that also block serotonin receptors. It may be preferred when clinicians seek a medication with less metabolic impact but need careful monitoring for movement‑related side effects.

Nodasic should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Nodasic is taken orally, usually as a tablet. It should be swallowed whole with water, and the exact timing (e.g., with or without food) is directed by the prescribing physician.

Serious risks include neuroleptic malignant syndrome, severe hypotension, QT‑interval prolongation, agranulocytosis, and significant extrapyramidal reactions such as persistent dystonia or parkinsonism. Patients should be monitored closely for any of these events.

Nodasic is contraindicated in patients with known hypersensitivity to amisulpride or any of its excipients, those with a history of severe cardiac arrhythmias, and individuals with uncontrolled severe renal impairment unless dose adjustments are made under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Amisulpride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT